Yael Margolin
Director/Miembro de la Junta en SCINAI IMMUNOTHERAPEUTICS LTD. .
Fortuna: 926 $ al 30/06/2024
Origen de la red de primer grado Yael Margolin.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
26
| Public Company | Pharmaceuticals: Major | 26 |
Tau Ventures Ltd.
 Tau Ventures Ltd. Investment ManagersFinance TAU Ventures Ltd (TAU Ventures) is a venture capital subsidiary of Tel-Aviv University founded in 2017 by Behzad Kianmahd. The firm is headquartered in Tel Aviv, Israel.
21
| Operating Division | Investment Managers | 21 |
| Public Company | Pharmaceuticals: Other | 18 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Pharmaceuticals: Major | 15 | |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.
13
| Subsidiary | Miscellaneous Commercial Services | 13 |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Part of Gamida Cell Ltd., Gamida Cell, Inc. develops cellular and immune therapeutics. The company is based in Medfield, MA. The CEO of the company is Julian Adams.
8
| Subsidiary | Biotechnology | 8 |
Welltech Ventures
 Welltech Ventures Investment ManagersFinance Welltech Ventures is a venture capital firm founded in 2019 by Galit Horovitz and Amir Alroy. The firm is headquartered in Tel Aviv, Israel.
8
| Private Company | Investment Managers | 8 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Yale School of Medicine
2
| College/University | Other Consumer Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Yael Margolin a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Doctorate Degree President Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| Bar-Ilan University | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Undergraduate Degree Graduate Degree | |
| Weizmann Institute of Science | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| Boston University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member Chief Executive Officer | |
| DICE THER | Biotechnology | President Director/Board Member Director/Board Member Corporate Secretary | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President Director/Board Member Corporate Secretary | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Executive Officer | |
| University of Toronto | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
PricewaterhouseCoopers (Israel)
 PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Israel) provides legal services. The company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Chief Executive Officer Comptroller/Controller/Auditor Director/Board Member | |
| A.Y.R.A.D. Investment Ltd. | Chief Executive Officer Chief Executive Officer Chief Investment Officer | ||
| TOGETHER PHARMA LTD | Pharmaceuticals: Other | Director/Board Member Director of Finance/CFO Director/Board Member | |
| KAMADA LTD. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Investor Relations Contact | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor | |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| London School of Economics & Political Science | College/University | Undergraduate Degree Undergraduate Degree | |
| MATRICELF LTD | Biotechnology | Director/Board Member Director/Board Member | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PFENEX INC. | Biotechnology | Director/Board Member Founder | |
ProScript, Inc.
 ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Dreamed Diabetes Ltd.
 Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014. | Packaged Software | Director/Board Member Director/Board Member | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Medical Specialties | President Director/Board Member | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| KADIMASTEM LTD | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
Giza Venture Capital
 Giza Venture Capital Investment ManagersFinance Giza Venture Capital (Giza Venture) is a venture capital firm founded in 1992 by Zeev Holtzman and Zvi Schechter. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Corporate Officer/Principal Director of Finance/CFO | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Chairman Investor Relations Contact | |
| Bioline Innovations Jerusalem LP | Corporate Officer/Principal Corporate Officer/Principal | ||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
| Reichman University | College/University | Undergraduate Degree Compliance Officer | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | President Chief Executive Officer | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Private Equity Investor Chief Executive Officer | |
| EVOGENE LTD. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor |
Estadísticas
Internacional
| Israel | 29 |
| Estados Unidos | 19 |
| Canadá | 4 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 23 |
| Consumer Services | 18 |
| Commercial Services | 5 |
| Finance | 5 |
| Technology Services | 2 |
Operativa
| Director/Board Member | 448 |
| Corporate Officer/Principal | 155 |
| Independent Dir/Board Member | 102 |
| Undergraduate Degree | 76 |
| Chief Executive Officer | 72 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Eric Rowinsky | 36 |
| Uri Ben-Or | 32 |
| Michal Marom Brikman | 32 |
| Ofer Gonen | 31 |
| Hadar Resnekov-Ron | 31 |
| Eli Alroy | 28 |
| Michael Perry | 28 |
| Eden Shochat | 26 |
| Richard Carmona | 26 |
| Jonathan Goodman | 25 |
| Roger Kornberg | 24 |
| Yisrael Gewirtz | 24 |
| Myles D. Greenberg | 23 |
| Julian Adams | 23 |
| Boaz Lifschitz | 23 |
- Bolsa de valores
- Insiders
- Yael Margolin
- Conexiones Empresas
